Recently, the miR-126 that is known to regulate angiogenesis has been found to control cancer metabolism by targeting the insulin receptor substrate-1 (IRS1).39, 71 IRS1 is an adaptor proteins involved in signaling via insulin receptor (IR) and insulin-like growth factor I receptor (IGF-IR). This evidence concerns the gene IRS1 and cancer.